Medically Reviewed · CliniqWise Clinical Advisory Board — Endocrinology Panel · Updated 2026-08-27

HOMA-IR Calculator — Homeostatic Model Assessment of Insulin Resistance

Calculate HOMA-IR from fasting insulin and fasting glucose to quantify insulin resistance and screen for metabolic syndrome and early Type 2 Diabetes.

⚙️

HOMA-IR Calculator

Enter values below to calculate

mg/dL
µIU/mL

This calculator is for informational and educational purposes. Results should be interpreted with clinical judgment and local guidelines.

What is HOMA-IR (Homeostatic Model Assessment of Insulin Resistance)?

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a mathematical model developed by Matthews et al. in 1985 to estimate insulin sensitivity and beta-cell function from fasting plasma glucose and fasting insulin levels. In healthy individuals, fasting glucose and insulin maintain a homeostatic feedback loop. As tissues become resistant to insulin (insulin resistance), the pancreas secretes higher baseline levels of insulin to keep fasting blood glucose in the normal range. HOMA-IR quantifies this hyperinsulinemic compensation. It correlates strongly with the hyperinsulinemic-euglycemic clamp (the gold standard research method) while requiring only a single fasting blood sample, making it ideal for clinical assessment of Metabolic Syndrome, PCOS, and prediabetes.

HOMA-IR (Conventional Units) = [Fasting Glucose (mg/dL) × Fasting Insulin (µIU/mL)] / 405. HOMA-IR (SI Units) = [Fasting Glucose (mmol/L) × Fasting Insulin (µIU/mL)] / 22.5. Normal: < 1.0; Optimal: < 1.9; Elevated Insulin Resistance: > 2.9.

When to Use the HOMA-IR Calculator

  • Screening for occult insulin resistance in individuals with normal fasting glucose but clinical features of Metabolic Syndrome (central obesity, acanthosis nigricans, dyslipidemia).
  • Evaluating insulin resistance in Polycystic Ovary Syndrome (PCOS) to guide lifestyle and metformin therapy.
  • Assessing cardiovascular metabolic risk in non-diabetic individuals with family history of Type 2 Diabetes.
Insulin ResistanceMetabolic SyndromePolycystic Ovary Syndrome (PCOS)Prediabetes EvaluationNonalcoholic Fatty Liver Disease (NAFLD/MASLD)

HOMA-IR Mathematical Formula

Conventional Formula (Glucose in mg/dL)

HOMA-IR = [Fasting Glucose (mg/dL) × Fasting Insulin (µIU/mL)] / 405

Fasting Glucose = 95 mg/dL, Fasting Insulin = 10 µIU/mL → HOMA-IR = (95 × 10) / 405 = 950 / 405 = 2.35

SI Units Formula (Glucose in mmol/L)

HOMA-IR = [Fasting Glucose (mmol/L) × Fasting Insulin (µIU/mL)] / 22.5

Fasting Glucose = 5.28 mmol/L, Fasting Insulin = 10 µIU/mL → HOMA-IR = (5.28 × 10) / 22.5 = 2.35

Variables

Fasting Glucose (mg/dL (or mmol/L))

Blood glucose after an 8–12 hour overnight fast.

Fasting Insulin (µIU/mL (or mIU/L))

Serum insulin level after an 8–12 hour overnight fast.

405 is the constant derived from normalizing fasting glucose (5 mmol/L = 90 mg/dL) × fasting insulin (5 µIU/mL) = 22.5 (22.5 × 18 = 405).

HOMA-IR Score Cutoffs & Clinical Interpretation

General population cutoffs for insulin resistance.

RangeClassificationHealth Risk
< 1.0
Optimal Insulin Sensitivity
High insulin sensitivity; low metabolic risk.
1.0–1.9
Normal / Mildly Elevated
Healthy baseline for most healthy adults.
2.0–2.9
Early Insulin Resistance
Subclinical insulin resistance. Lifestyle modifications recommended.
≥ 3.0
Significant Insulin Resistance
Significant insulin resistance. Strongly associated with PCOS, Metabolic Syndrome, and future T2DM.

Specific cutoffs vary by ethnicity and assay methodology. In South Asian populations, a HOMA-IR cutoff of > 2.0 is often used for insulin resistance due to higher body fat percentage at lower BMI.

Limitations & Clinical Warnings

1.

Requires strict 8–12 hour fasting state. Non-fasting samples severely distort results.

2.

Not applicable in patients taking exogenous insulin (insulin antibodies interfere with immunoassay).

3.

In severe beta-cell failure (advanced T2DM), insulin levels fall, causing falsely low HOMA-IR despite extreme insulin deficiency.

Medical Disclaimer

HOMA-IR is an assessment tool for research and clinical risk stratification. Integrate with HbA1c, lipid panel, and waist circumference.

References & Citations

  1. Matthews DR, Hosker JP, Rudenski AS, et al.. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man”. Diabetologia. 1985. 28(7): 412–419. PMID: 3899825 | DOI: 10.1007/BF00280883
  2. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling”. Diabetes Care. 2004. 27(6): 1487–1495. PMID: 15161807 | DOI: 10.2337/diacare.27.6.1487

Medically Reviewed

Reviewed by CliniqWise Clinical Advisory Board — Endocrinology Panel · Last updated: 2026-08-27 · Next review: 2027-02-27

Frequently Asked Questions

Common Questions About HOMA-IR Calculator

Explore More Medical Calculators

Browse the CliniqWise calculator library by specialty, score, disease area, or clinical task.

Browse All Calculators
Support Online Now

Live Consultation

Have questions about ABDM, billing, or features? Talk to our health-tech experts instantly.